NA
APYX icon

NewEdge Advisors’s Apyx Medical APYX Stock Holding History

NewEdge Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Buy
95,815
+26,640
+39% +$106K ﹤0.01% 2235
2026
Q1 		$255K Buy
+69,175
New +$259K ﹤0.01% 2455
2024
Q3 		– Sell
-75
Closed -$101 – 3816
2024
Q2 		$101 Buy
+75
New +$111 ﹤0.01% 3690
2023
Q2 		– Sell
-117
Closed -$337 – 3489
2023
Q1 		$337 Hold
117
– – ﹤0.01% 3277
2022
Q4 		$0 Buy
+117
New +$357 ﹤0.01% 4084

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NewEdge Advisors's APYX Position: Q2 2026 in Review

NewEdge Advisors increased its Apyx Medical (APYX) stake by 39% in Q2 2026, buying an estimated $106K and bringing the position to 95,815 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

NewEdge Advisors first reported a position in APYX in Q4 2022 and has held it in 5 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • NewEdge Advisors held 95,815 shares of Apyx Medical worth $430K as of Q2 2026.
  • NewEdge Advisors bought 26,640 Apyx Medical shares in Q2 2026, an estimated $106K.
  • Apyx Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2235 holding.
  • NewEdge Advisors first reported a position in Apyx Medical in Q4 2022 and has held it in 5 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.